The Value Hunter
252 posts







From gene therapy to vaccines, these innovators reshaped medicine: Suma Krishnan: She created the first topical gene therapy for skin diseases. Patrick Soon-Shiong: He invented better drug delivery and founded a biotech empire. Noubar Afeyan's factory for life science startups has launched more than 100 companies, including Moderna. Jonas Salk developed the first successful polio vaccine. See where they land on the #Forbes250: America's Greatest Innovators list: forbes.com/lists/forbes-2… (Credit: Suma Krishnan By Jamel Toppin For Forbes, Patrick Soon-Shiong By Ethan Pines For Forbes, Jonas Salk by PhotoQuest-Getty Images, Noubar Afeyan By Michael Prince For Forbes)

FDA is holding up approval for Dr. Soon Shiong's Anktiva for papillary bladder cancer. Take a minute to look at the cancer-free statistics from ChatGPT for Merck's Keytruda, which was approved for papillary bladder cancer, vs Anktiva, which has yet to be approved for papillary bladder cancer, despite the fact that Anktiva is the superior drug for this disease. At 24 months: Keytruda: ~30–40% disease-free. Anktiva+BCG ~52% disease-free. At 3 years: 73% of Keytruda patients kept their bladders. 82% of Anktiva + BCG patients kept their bladders. At 3 years: Keytruda overall survival: ~90% Anktiva + BCG overall survival: ~96% Dr. Makary, Dr. Bhattacharya, Sec Kennedy, please do the right thing and approve Anktiva for papillary bladder cancer now. Save more lives. Please help spread the word & retweet this post. @DrMakaryFDA @DrPatrick @ImmunityBio @DrJBhattacharya @ChrisCuomo @SecKennedy @LoriMills4CA42 @tteuscher @CarnivoreKen @julie_bush @bullishbruk @exosome @Johnincarlisle @chrisca70578779


The year of the fire horse. Now in Italy and inspecting our Ai driven robot nearing completion and a stainless steel horse in the lobby. A good sign of what is to come!! World Bank of NK cells.

Almost there! We will transform cell therapy at scale. Beautifully made robot

$IBRX red to green



